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Cytokine Production in the Serum and Spleen of Mice
from Day 6 to 14 of Gestation: Cytokines/Placenta/
Spleen/Serum
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Department of Biology, University of Crete, P.O, Box 1470, 711 10 Heraklion, Crete, Greece
Pregnancy, like most biologic phenomena, involves the action of cytokines. These proteins
have a short half-life and are believed to exert their effect close to their site of production,
where diagnostic tests cannot be easily performed. Here we show that the cytokine con-
tent in the maternal serum reflects cytokine production and secretion from maternal spleen
cells, which also correlates with production from decidual cells. We show that GM-CSF, IL-
3, and IL-10 are present in the serum at specific time intervals during the first half of murine
pregnancy, which correlates with their production from maternal spleen cells. Purified
GM-CSF and IL-3 from spleen-cell-culture supernatants are biologically active molecules,
able to stimulate placental-cell proliferation. Furthermore, TNF-0, which has been identi-
fied in many cases of fetal rejection as well as in labor, is shown to be naturally produced
during the second half of pregnancy. Additionally, within the limits of the sensitivity of the
technique we have used, the detection of IL-4 and the absence of detectable levels of IL-
2 in the maternal serum strongly comforts the hypothesis that pregnancy is a Th2-depend-
ent phenomenon. The results presented in this paper show that the cytokine profile during
pregnancy can be monitored by simple blood tests, which may be of relevance both in the
followup of a physiological human pregnancy and to the diagnosis of recurrent abortions
due to cytokine imbalance.
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INTRODUCTION
During the gestational period, the maternal immune
system is being stimulated by paternal alloantigens,
which are introduced in the maternal organism
through the semi-allogeneic fetus they carry. These
alloantigens can be detected either in the maternal
blood, where fetal cells have been found to circulate
in mice and humans (Douglas et al., 1959; Schroder,
1975; Herzenberg et al., 1979; Bianchi et al., 1990;
Bruch et al., 1991). In mice, they are expressed on
the outer trophoblastic layer of the semi-allogeneic
placental tissue, which comes in direct contact
with the maternal circulation (McLaren, 1975;
Raghupathy et al., 1981). Many studies so far indi-
cate that at the cellular level, the maternal immune
stimulation is manifested via two essential mecha-
*Corresponding author.
nisms. The first consists of an immunotrophic activ-
ity of the maternal immune system toward the
developing feto-placental annexes (James, 1965;
Wegmann, 1984; 1987), whereas the second involves
an immunosuppressive activity of the maternal
immune response toward paternal alloantigens
(Slapsys and Clark, 1983, Chaouat et al., 1984; Sano
et al., 1984). For a long time, the immunotrophic and
immunosuppressive hypotheses were considered as
mutually exclusive and scientists were trying to give
evidence for either one. Regarding the immuno-
trophic hypothesis, there is evidence that maternal
T cells and T-cell-derived lymphokines stimulate
placental-cell growth and improve fetal survival
(Wegmann, 1984; Athanassakis et al., 1987). On the
other hand, the existence of anti-paternal suppres-
sor factors and suppressor cells during pregnancy
support the immunosuppressive hypothesis (Smith
and Powell, 1977; Engleman, et al., 1978; Slapsys and
Clark, 1983; Sano et al., 1984; Clark et al. 1990). How-
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ever, it is now believed that these two theories are
not mutually exclusive and that both drive the ma-
ternal organism to cytokine production regulating
important steps of successful pregnancy, which is
hypothesized to be a Th2-dependent phenomenon
(Wegmann et al., 1993).
Here we study six cytokines, referenced to be
involved in the process of successful pregnancy.
Interleukin-3 (IL-3) and granulocyte-macrophage
colony-stimulating factor (GM-CSF) have been de-
scribed to stimulate growth and function of tro-
phoblasts (Athanassakis et al., 1987). Interleukin-10
(IL-10) shows a protective effect to the materno-
fetal allograft, rescuing fetal rejection in abortion-
prone mice (Chaouat et al., 1995). Tumor necrosis
factor-0 (TNF-a) has been detected in many cases of
abortion models and its beneficial or destructive
presence during pregnancy is questioned in many
instances (Parand and Chedid, 1964; Gendron et al.,
1989; Chaouat et al., 1990; Yelavarthi et al., 1991).
In order to distinguish between Thl and Th2 cell
populations, this study also included detection of
interleukin-2(IL-2) and interleukin-4(IL-4) in the
serum of pregnant mice, lymphokines that are spe-
cifically secreted by the two populations, respec-
tively (Mossman et al., 1989).
To obtain as complete an estimate as possible of
the bidirectional maternal immune reaction, it was
decided to initially follow the positive regulatory
signals transmitted by the maternal organism that
are directed toward placental growth. Such positive
reactions in the maternal spleen and decidual cap
were indentified in previous studies by the produc-
tion of pregnancy-specific growth factors in these
tissues (Athanassakis-Vassiliadis 1992; Tsoukatos
et al., 1994).
Because we aimed at designing a single method
for the followup of pregnancy, we investigated, in a
first step, whether the cytokine profile observed in
the maternal serum from day 6 to 14 of gestation
would reflect the cytokine production in the mater-
nal spleen. We show that this is indeed the case, and
confirm that the production of trophoblast-stimulat-
ing lymphokines is a systemic phenomenon. There-
fore, it could be followed during pregnancy by
simple blood tests. Such an observation could be
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FIGURE 1. Analysis of GM-CSF, IL-3, IL-10, TNF-o, IL-2, and IL-4 in the serum of virgin or pregnant mice from day 6 to 14 of
gestation by ELISA. The results are expressed as the percentage of optical density above background levels. The values correspond-
ing to virgin mice are shown at the beginning of the axes (NP). The results represent the mean of three mice tested in duplicates.
Each experiment was repeated three times and comparable results were obtained. In all cases, standard deviations do not exceed
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RESULTS
Detection of IL-2, IL-3, IL-4, IL-10, GM-CSF,
and TNF-c in the Serum of Pregnant Mice
Cytokine balance is now believed to play an impor-
tant role in the maintenance of pregnancy. In order
to define the physiological levels of IL-2, IL-3, IL-4,
IL-10, GM-CSF, and TNF-0, blood was collected from
mice from day 6 to 14 of gestation and the serum
was analyzed for the content of various cytokines
by ELISA. For each day of pregnancy, 3 mice were
sacrificed and their sera were run 3 times in dupli-
cates. The results, which represent the mean of all
the experiments, are shown in Fig. 1.
GM-CSF is showing a steady production from day
6 to 14 of gestation, where day-7 sera contain the
lowest amount of the factor and day 9 the highest;
IL-3 is detected in the serum after the tenth day of
pregnancy. IL-10 shows a peak of production on day
7 of pregnancy, which declines at lower levels until
the fourteenth day; TNF-0 increases after the sec-
ond half of pregnancy reaching a peak of produc-
tion on the twelfth day; IL-2 is found at low levels
throughout the days of pregnancy tested, which do
not differ from the IL-2 production observed in
nonpregnant mice (in the same experiments, IL-2
could be detected in ConA-stimulated spleen-cell-
culture supernatants- data not shown); IL-4 is gen-
erally present in the serum of pregnant mice at higher
amounts than nonpregnant mice and shows two
peaks of production on days 10 and 12 of pregnancy.
tent markedly decreases; IL-3-secreting cells are
detected in the spleen only on days 6 and 7 of ges-
tation, which indicates a cessation of its production
thereafter; IL-10-secreting cells show a similar peak
of stimulation on day 7 of pregnancy, a pattern that
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Detection of IL-3, IL-10, and GM-CSF in
the Spleen of Pregnant Mice
Previous studies have shown that specific growth-
factor production during pregnancy takes place not
only at the proximity of the feto-placental unit-
decidual cap (Athanassakis-Vassiliadis, 1993), but in
the maternal spleen as well (Tsoukatos et al., 1994).
Therefore, similar analysis was performed on the
spleen cells of pregnant mice from day 6 to 14 of
gestation, where the percentage of cytokine-secret-
ing cells was estimated by intracellular immuno-
fluorescence. The results, which represent the same
number of mice and experiments mentioned in the
previous section, are shown in Fig. 2.
GM-CSF-secreting cells are showing a constant
pattern from day 6 to 14 of gestation, which corre-
lates with the appearance of this factor in the serum,
with an exception on day 7 of pregnancy, when the






FIGURE 2. Detection of intracellular GM-CSF, IL-3, and IL-10
in the spleen of virgin or pregnant mice from day 6 to 14 of
gestation by immunofluorescence. The results are expressed as
the percentage of positive cells above background levels. The
values corresponding to virgin mice are shown at the beginning
of the axes (NP). The results represent the mean of three mice
tested in duplicates. In all cases, standard deviations do not
exceed 2%.250 I. ATHANASSAKIS and B. ICONOMIDOU
Spleen-Cell-Culture Supernatants from
Gestating Mice Contain GM-CSF and IL-3
Among the cytokines tested so far, special care is
given to GM-CSF and IL-3, which are known to for-
tify the placental barrier by stimulating trophoblast
growth and phagocytosis (Athanassakis et al., 1987).
The results presented in the previous section show
that indeed GM-CSF- and IL-3-producing cells are
present in the spleen. In order to test whether these
lymphokines also can be found in secreted form, we
collected 24-hr-culture supernatants from mice at
different days of pregnancy, purified them through
affinity columns, and tested the presence ofGM-CSF
and IL-3 in the resulting column fractions by ELISA.
Thus, pregnant mice from day 9 to 13 of gestation
(three mice for each day of pregnancy) were sacri-
ficed, the spleens were removed, put in cell suspen-
sion, and cultured for 24 hr in a serum-free culture
medium. The culture supernatants were individu-
lymphokine is detected on days 9, 10 and 11 of preg-
nancy (Fig. 3). Although virgin females show some
production of this factor (10% increase over back-
ground), during pregnancy, IL-3 doubles its produc-
tion.
Spleen-Cell-Culture Supernatants from
Gestating Mice Contain Proteins Stimulating
Placental Cell Growth
In order to test whether the growth factors contained
in the various affinity column fractions of spleen-
cell supernatants may influence placental-cell
growth, we applied purified supernatants to placen-
tal cells and assayed 4 days later for cell prolifera-
tion by 3HTdR uptake. The results show that indeed
biologic activity can be detected in various column
fractions (Fig. 4). The general pattern of biologic
activity can be divided in four peaks according to
the NaC1 concentration used for elution: (1) 200-400,
ally loaded on the top of a Heparin Sepharose CL- (2)400-600, (3)600-800, and (4)800-1000mM NaC1.
6B affinity column and eluted with a gradient of
NaC1 (0.1 to 1.1 M). The resulting fractions were
dialyzed against PBS, their protein content deter-
mined, and the same amount of protein from each
fraction was assayed for the presence of GM-CSF
and IL-3. As shown in Fig. 3, GM-CSF is detected
in fractions eluted with 200-700 mM NaC1 and
maximal values are obtained on days 9 and 11. In
nonpregnant mice, no GM-CSF could be detected in
any of the fractions of the spleen-cell supernatants,
indicating that the increased production ofGM-CSF
is related to the gestating cycle of the mother.
IL-3 was eluted with 200-600 mM NaC1. This
Peak number I was active only on the tenth day of
pregnancy, when it showed a twofold increase in
placental-cell proliferation over background. The
second peak gave an increasing activity from day 9
of pregnancy, reaching highest levels on the elev-
enth day and showing only background activity on
the thirteenth day of syngeneic pregnancy. Peak 3
gave the highest levels of biologic activity on the
twelfth day of pregnancy (sevenfold). With the
fourth peak, an increasing biologic activity was
observed from day 9 of pregnancy, reaching maxi-
mal levels by day 12. Although the peaks of activity
seen on days 9, 10, and 11 may correspond to the
3 S 7 3 5 7 3 5 7 3 5 7





MOLARITY NaCI (ram 10"2)
FIGURE 3. Analysis of affinity column fractionated spleen-cell-culture supernatants in pregnant mice from day 9 to 13 of gesta-
tion. Biologic activity was determined as the ability of the resulting factors to stimulate placental cell proliferation (see
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FIGURE 4. Analysis of GM-CSF (A) and IL-3 (B) content in the affinity column fractionated spleen-cell-culture supernatants in
pregnant mice. This analysis was performed using the ELISA technique (see Materials and Methods) and the results are expressed
as the percentage of optical density above background levels. GM-CSF could not be detected in fractionated spleen-
cell-culture supernatnats from nonpregnant controls, whereas IL-3 content in the fractionated spleen-cell-culture supernatants from
nonpregnant controls showed a 10% activity over background.252 I. ATHANASSAKIS and B. ICONOMIDOU
already defined GM-CSF and IL-3 growth factors,
the results show that additional placental growth
factors are secreted on day 12 of pregnancy.
DISCUSSION
During the physiological process of pregnancy, the
fetal allograft develops in a restricted site of the
maternal body, the uterus, which is somehow shed
from the rest of the maternal organism. Important
regulatory maternal/fetal interactions take place at
the uterine site, where fetal annexes come in direct
contact with the maternal circulation. From the
moment of fertilization, a plethora of growth factors
produced in the uterus harmonically exert their ac-
tion to ensure the development of the fetal allograft
(Hill, 1991; Lea et al., 1992; Lin et al., 1993; Delassus
et al., 1994). However, the uterus is not the only site
affected by fetal growth. Changes also occur in the
we show that TNF-a is present in the maternal
serum after the second half of pregnancy and its pro-
duction peaks on day 12. This observation places
TNF-a among the cystostatic factors induced later
in pregnancy, which are necessary to restore equi-
librium via-a-vis the stimulatory factors produced
at the beginning of the gestational period.
The presence of these factors in the maternal
serum places once more T cells in the first line of
interest (Heyborn et al., 1992), because under physi-
ological conditions, these consist of the primary
source of the earlier proteins. In an attempt to dis-
tinguish between Thl and Th2 subpopulations, we
determined the IL-2 and IL-4 content of the mater-
nal serum, lymphokines known to be specifically
produced by the two cell types, respectively. Al-
though the amounts of IL-2 do not differ from those
of virgin mice, the production of IL-4 was found to
increase during pregnancy, showing two peaks on
days 10 and 12, results arguing for a Th2-dependent
rest of the maternal organism that should play an -pregnancy process, as it has been postulated by
equally important role in fetal growth and survival.
Previous studies have shown that spleen cells on the
eleventh day of pregnancy produce placenta-specific
growth factors, which are not seen in virgin females
(Tsoukatos et al., 1994). In order to examine whether
such cytokine changes can be detected in the mater-
nal serum and whether these reflect the situation
observed at specific sites of the maternal organism,
in the present study; we compared the cytokine con-
tent in the maternal serum from day 6 to 14 of ges-
tation with the growth factors produced and secreted
by spleen cells within the same time intervals. The
results demonstrate that the cytokine profile in the
serum correlates with that of maternal spleen and
furthermore with the local production of growth
factors by decidual cells (Athanassakis-Vassiliadis,
1993).
The profile of GM-CSF, IL-3, IL-10, TNF-c, IL-2,
and IL-4 in the maternal serum was determined by
ELISA. GM-CSF and IL-3 are known to directly af-
fect fetal development by stimulating trophoblast
proliferation, whereas IL-10 has been shown to res-
cue fetal abortion in mice (Chaouat et al., 1995). The
results show that the production of these lympho-
kines is not simultaneous, because IL-10 peaks on
day 7 of pregnancy, GM-CSF on day 9, and IL-3 on
day 10. Consequently, it can be postulated that these
factors serve different stages of fetal development.
The presence of TNF-0 has been correlated with
fetal abortion in many systems (Parand and Chedid,
1964; Gendron et al., 1989; Chaouat et al., 1990). Here
Wegmann et al. (1993).
In order to define whether spleen is one of the sites
of production of such growth factors, we stained
maternal spleen cells with specific monoclonal anti-
bodies and showed that indeed IL-10-secreting cells
are present in the maternal spleen, following a pro-
file similar to that of maternal serum. Intracellular
GM-CSF, which with an exception on day 7 of ges-
tation follows a similar pattern to the seric factor, is
also being secreted by spleen cells because it can be
detected in the 24-hr culture supernatants of spleen
cells at the equivalent days of pregnancy. The high-
est concentration of IL-3-secreting cells is detected
in the spleen of days 6 and 7 of pregnancy, which,
however, does not correspond to the highest con-
centration of the factor detected in the serum. This
form of IL-3 is either nonsecreted or it is at the be-
ginning of its biosynthesis, because IL-3 can be de-
tected in the 24-hr culture supernatants from day
9 of pregnancy. Furthermore, GM-CSF and IL-3
secreted by spleen cells are biologically active be-
cause they can stimulate placental cells to prolifer-
ate. The differences observed between seric and
intracellular growth factors can be due to the pres-
ence of soluble receptors, to different sites of action
as well as to the difference in factor half-life, points
that need to be investigated in the future. The fac-
tors studied here are naturally not the only ones
involved in the gestational process. Indeed, when
fractions of the 24-hr-spleen-cell culture super-
natants, other than IL-3 and GM-CSF, were appliedCYTOKINE PRODUCTION DURING MURINE PREGNANCY 253
to placental cells, these were able to stimulate
growth.
These results give new insight in the regulatory
mechanisms taking place during pregnancy. Each
growth factor follows a specific pattern of produc-
tion, likely to serve specific needs of the materno/
fetal organism during gestation. One important
observation is that growth-factor production is a
systemic phenomenon during pregnancy and that
its presence in the maternal serum correlates with
its production from spleen and possibly other sites
close to the feto-placental unit. A similar method as
the one used for the murine growth-factor profiles
analyzed here may be employed in humans, to al-
low to study the physiological levels of cytokines
throughout the gestational period. Several abortive
causes have been correlated to specific growth fac-
tor over or under production. Therefore, with sim-
ple blood tests, we may follow not only the progress
of fetal development, butwe can also prognose cases
of recurrent abortion.
without serum for 24 hr at a concentration of I x 10
cells/ml. Culture supernatants (10 ml) were collected
after centrifugation of the cells at 1200 rpm for 10
min. Three mice were tested in each day of preg-
nancy in the allogeneic and syngeneic situation.
Partial Fractionation of Spleen-Cell
Supernatants
This fractionation was performed as described by
Tsoukatos et al. (1994) with slight modifications.
Briefly, three samples of 10 ml spleen cell super-
natant, obtained from three different mice were
pooled, dialyzed against PBS, and passed through a
Heparin Sepharose CL 6B affinity column. The col-
umn was equilibrated with buffer A (20 mM Tris,
pH 7.4, 100mM NaC1) following a flow rate of 5 ml/
hr. The column was then washed with buffer A,
loaded with the sample and a gradient (50 ml) of 0
to 1 M NaC1 was applied. Fractions of 5 ml were
collected, dialyzed against PBS, and kept at4C until
assayed on placental cell proliferation.
MATERIALS AND METHODS Placental Cell Cultures
Mice
BALB/cJ(H-2d) 6-8 weeks old were maintained in
the animal facility at the University of Crete (Crete,
Greece). Each female was checked for oestrus, caged
overnight with a BALB/cJ male, and checked for the
presence of a vaginal plug on the following morn-
ing. The day on which the plug was observed was
considered to be day 0 of pregnancy.
Antibodies
Rat anti-mouse IgG2a monoclonal antibodies to the
growth factors GM-CSF (sensitivity 5 tg/ml), IL-3
(sensitivity 3 tg/ml), IL-10 (sensitivity 0.14 U/ml),
TNF- (sensitivity 25 f)g/ml), IL-2 and IL-4 (sensi-
tivity 5 tg/ml) were purchased from Endogen Inc.
(Cambridge, MA), and were used at the concentra-
tion of I tg/ml.
Spleen-Cell Cultures
Spleens were obtained either from pregnant or con-
trol nonpregnant BALB/cJ females from day 9 to 13
of gestation. Cell suspensions were washed in
Hank’s solution (Gibco, Grand Island, NY) three
times and cultured in RPMI 1640 medium (Gibco)
Placental cell cultures were performed as described
by Athanassakis et al. (1987) with slight modifica-
tions. Briefly, placentas were isolated from females
on day 11 to 14 of gestation and after removing the
maternally derived decidual cap layer from all pla-
centas, the tissues were cut in small pieces, and sin-
gle-cell suspensions were prepared by passing the
preparation through a syringe with a 18- G needle,
into Hank’s solution (Athanassakis et al. 1987; 1989).
As previously reported, this is a very mild technique
for isolating trophoblasts from the murine placenta,
yielding 95 to 100% viable cells. The cell types iso-
lated by the method used include the adherent
spongiotrophoblasts (19+2%), labyrinthine tropho-
blasts (69+8%), macrophages (3+1%), and red cells.
3H-Thymidine (3HTdR) incorporation assays fol-
lowed by autoradiography demonstrate that only the
adherent placental cells proliferate in a cell culture
(Athanassakis et al., 1993), which are also found to
be cytokeratin-positive and vimentin-negative (tro-
phoblasts; Athanassakis, 1987). For each experiment,
placental cells from 3 to 4 mice (pool of 20 to 24
different placentae) were isolated as described be-
fore, washed three times, and cultured at the con-
centration of I x 10 cells/ml in RPMI 1640 medium
supplemented with 20% fetal calf serum (FCS,
Seralab, Sussex), in 96-well plates (Linbro, McLean,254 I. ATHANASSAKIS and B. ICONOMIDOU
VA) with or without the presence of the fractionated
spleen-cell supernatants at a final volume of 200 gl/
well in triplicates. Protein fractions from the Heparin
column were used at 1:2 dilution. Cultures were as-
sayed for 3H-Thymidine 3HTdR, NEN, Du Pont,
Paris) incorporation on day 4. This time period was
found to be the most appropriate to placental cell
cultures, where all cells have gone through two cell
cycles and maintain their full viability (Athanassakis,
1993). One gCi of 3HTdR was added per well 18 hr
prior to harvest. The cells were collected with
vacaum aspiration on cellulose filters. By using an
automatic titertec cell harvester (Flow Labs), free
3HTdR was washed away with repeating flashes of
ddH20. The filters were air dried, placed in scintil-
lation fluid (toluene supplemented with 1.38 g/1
omnifluor, NEN), and counted in a LKB 1218
Rackbeta counter. These experiments were repeated
three times for each set of column fractions, for each
day of pregnancy tested, and gave comparable re-
sults.
Indirect ELISA
Mouse serum, collected from virgin or pregnant mice
from day 6 to 14 of gestation, was used at the dilu-
tion of 1/1000 in carbonate buffer pH 9.6. Protein
concentration (mg/ml) in the different column frac-
tions was estimated by measuring the optical den-
sity at 280 and 260 nm using a spectrophotometer
(Hitachi K-1100) and applying the formula: (1.45 x
Absorption 280) (0.74 x Absorption 260). Each frac-
tion was coated at the concentration of 5 gg/ml in
carbonate/bicarbonate buffer, pH 9.6. All serum
samples or fractionated spleen-cell-culture super-
natants were coated in the same 96-well ELISA plate
(Nunc, Kampstrup, Denmark), incubated overnight
at 4C, and washed four times in 5% Tween-20. The
remaining sites were blocked by a 2% PBS-BSA so-
lution after incubation for 2 hr at room temperature.
After washing four times as described before, 100 gl
of the different antibodies, diluted in 0.1% PBS-BSA,
were added and incubated for I hr at room tempera-
ture. After washing, 100 gl of goat anti-mouse IgG
coupled to horseradish peroxidase (1:1000 dilution,
Sigma) was added and incubated for 1 hr at room
temperature, in the dark. The plate was then washed
and 100 gl/well of tetramethyl benzidine-H20
(Sigma) were added and incubated for 20 min. The
enzymatic reaction was stopped by adding 50 gl
H2SO (4N). Optical density (OD) was measured
at 450 nm using a Titertec ELISA photometer
(Multiskan Plus). The ELISA test was performed at
least three times for each set of affinity-purified
column fractions. The results were expressed as the
percentage ofOD increase over background (OD of
antibody alone).
Indirect Immunofluorescence
Immunofluorescent staining of cytoplasmic growth-
factor production was performed as described by
Sander et al. (1991). Maternal spleen cells from day
6 to 14 pregnancy were put in a single-cell suspen-
sion, washed several times, and fixed with ice-cold
paraformaldehyde (4% in PBS) for 5 min. After
washing, the cells were incubated for 30 min at room
temperature with specific antibodies diluted in a
HBSS-Saponin solution (HBSS; Gibco, 0.01M Hepes;
Gibco, 0.1% Saponin, Sigma). After washing in PBS-
Saponin, the cells were incubated with rabbit anti-
rat IgG antibody FITC-conjugated for 30 min at room
temperature. The cells were washed, fixed with 25%
glycerol, mounted on slides, and examined for cyto-
plasmic staining using a Leitz fluorescent micro-
scope.
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